| Model-1 | Model-2 | Model-3 |
---|
ß |
p
| ß |
p
| ß |
p
|
---|
Systolic Blood Pressure |
 Adiponectin |
7.80
|
0.001
|
6.02
|
0.01
| 4.17 | 0.11 |
 Resistin |
-10.16
|
0.04
| -5.07 | 0.25 | -4.25 | 0.34 |
 PAI-1 |
-21.71
|
<0.001
|
-12.69
|
0.001
|
-10.83
|
0.008
|
 Leptin |
-8.89
|
<0.001
|
-6.89
|
<0.001
|
-6.14
|
0.005
|
 MCP-1 | -5.89 | 0.30 | -2.91 | 0.57 | -1.38 | 0.79 |
 Adipsin |
-18.20
|
0.009
| -5.16 | 0.44 | -3.62 | 0.59 |
Pulse Wave Velocity |
 Adiponectin | -0.34 | 0.30 |
-0.80
|
0.02
|
-1.05
|
0.003
|
 Resistin | -0.84 | 0.23 | -0.23 | 0.70 | -0.22 | 0.72 |
 PAI-1 | -0.62 | 0.28 | 0.72 | 0.18 | 0.90 | 0.11 |
 Leptin |
-0.58
|
0.02
| -0.39 | 0.12 | -0.34 | 0.27 |
 MCP-1 | -0.78 | 0.33 | -0.26 | 0.71 | -0.18 | 0.80 |
 Adipsin | -1.37 | 0.17 | 0.56 | 0.53 | 0.64 | 0.48 |
- For associations between adipokines and systolic blood pressure: Model-1: adjusted for age and sex; Model-2: adjusted for covariates in Model-1 + dialysis vintage, current smoker, interdialytic weight gain, diabetes mellitus, history of cardiovascular disease, use of antihypertensives, log – weekly EPO dose, total and HDL cholesterol; Model-3: adjusted for covariates in Model-2 + BMI and log-CRP
- For associations between adipokines and pulse wave velocity: Model-1: adjusted for age and sex; Model-2: adjusted for covariates in Model-1 + dialysis vintage, current smoker, interdialytic weight gain, diabetes mellitus, history of cardiovascular disease, use of antihypertensives, use of statins, total and HDL cholesterol, systolic blood pressure and log-CRP; Model-3: adjusted for covariates in Model-2 + BMI
- Boldface entries are significant (p<0.05)